Teva UK Ltd and another v Astrazeneca AB [2014] EWHC 2873 (Pat), [2014] All ER (D) 44 (Sep)
The Patents Court considered challenges to the legitimacy of a patent for a treatment of asthma. It held that a challenge to the patent based on anticipation would be dismissed. However, a challenge to the patent on grounds of obviousness was made out and the patent was therefore invalid. A number of amended claims put forward by the owner of the patent would be rejected.
From mowing lawns to life at the Bar: Stephen Ward reflects on an unconventional career
Commercial property partner joins Clarke Willmott in Southampton
Robert Tiffen joins Ellisons as Partner in growing Norwich office
Jonathan Fisher KC highlights that it now accounts for around 40% of criminal offences, with roughly 70% involving technology, and argues that the UK cannot simply prosecute its way out of the problem. Detection, investigation and prosecution all require improvement, while different fraud types demand tailored responses.
